Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Secora files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Gibson - $3.96M of RXRX open-market activity in the last 12 months
- Blake Borgeson - $3.04M of RXRX open-market activity in the last 12 months
- Najat Khan - $179K of RXRX open-market activity in the last 12 months
- Ben R. Taylor - $68K of RXRX open-market activity in the last 12 months
- Namandje Bumpus - $28K of RXRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael Secora?
Michael Secora is a corporate insider, tracked as Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Secora last file a Form 4?
The most recent primary Form 4 on record is dated 19 November 2024, one of 3 filings going back to 2024.
Has Michael Secora been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($420K) across all tracked filings.
Where can I see all of Michael Secora's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael Secora and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
